3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
25
Carcinoma, Hepatocellular
22
Small Cell Lung Carcinoma
17
Lung Neoplasms
14
Neoplasms
13
Breast Neoplasms
9
Colorectal Neoplasms
7
Carcinoma, Renal Cell
7
Squamous Cell Carcinoma of Head and Neck
6
Urinary Bladder Neoplasms
5
Triple Negative Breast Neoplasms
5
Prostatic Neoplasms
5
Melanoma
5
Carcinoma, Transitional Cell
5
Uterine Cervical Neoplasms
4
Sarcoma
4
Neoplasm Metastasis
4
Glioblastoma
4
Stomach Neoplasms
3
Solid Tumors
3
Sarcoma, Alveolar Soft Part
3
Liver Neoplasms
3
Extensive Stage Lung Small Cell Carcinoma
3
Endometrial Neoplasms
3
Carcinoma
3
Treatment-Refractory Solid Tumors
2
Small Cell Lung Cancer Extensive Stage
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Osteosarcoma
2
Interventions
Specimen Handling
4
Magnetic Resonance Spectroscopy
4
Sunitinib
2
Everolimus
2
sargramostim
1
montanide ISA 51
1
lutetium Lu 177 dotatate
1
lanreotide
1
incomplete Freund's adjuvant
1
fludarabine phosphate
1
cabozantinib
1
belzutifan
1
X-Rays
1
Temozolomide
1
Phantoms, Imaging
1
Octreotide
1
Methods
1
Interleukin-13
1
Fluorodeoxyglucose F18
1
Cyclophosphamide
1
Colony-Stimulating Factors
1
Blood Specimen Collection
1
Biopsy
1
11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenoma, Islet Cell
×
atezolizumab
×
90 days
×
Clear all
No trials found.